Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome

NCT05726916 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Hypertensive Emergency-associated Hemolytic Uremic Syndrome

Interventions

DRUG: Soliris®
DRUG: Renin angiotensin system blockers

Sponsor

Assistance Publique - Hôpitaux de Paris